CONMED Corporation CNMD
Set alert
As of Nov 2, 10:44 AM ET
- YTD
- +12.84%
- 1 year
- +4.12%
- Open
- 44.76
- Prev close
- 44.29
- Mkt cap
- 1.37B
- Vol
- 41.41K
- Avg vol
- 381.16K
- EPS
- 2.41
- P/E
- 19.02
- Div yield
- 0.00%
More statistics
- Low
- 44.94
- High
- 45.86
- Forward P/E
- 9.27
- Beta
- 0.94
- Short ratio
- 4.85
- Inst. own
- 117.31%
- Dividend
- 0.80
- Ex-div date
- Sep 14, 2025
- Earnings
- Jan 27, 2027
- 50-d avg
- 47.22
- 200-d avg
- 41.40
- 1y target
- 46.83
News
-
3 days ago benzinga.com
JP Morgan Maintains Neutral on Conmed, Raises Price Target to $50
JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and raises the price target from $45 to $50.
-
4 days ago benzinga.com
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $49
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $46 to $49.
4 days ago marketbeat.com
CONMED Q3 Earnings Call Highlights
CONMED NYSE: CNMD reported third-quarter 2026 revenue of $335.6 million, with organic constant-currency sales growth of 6.7% as the medical technology company cited broad-based contributions from its…
4 days ago seekingalpha.com
CONMED Corporation (CNMD) Q3 2026 Earnings Call Transcript
CONMED Corporation ( CNMD ) Q3 2026 Earnings Call October 28, 2026 4:30 PM EDT Company Participants Patrick Beyer - President, CEO & Director John Gallagher - Executive VP, CFO and Principal…
4 days ago zacks.com
Conmed (CNMD) Q3 Earnings Top Estimates
Conmed (CNMD) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $1.08 per share a year ago.
4 days ago zacks.com
Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 Earnings
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
4 days ago benzinga.com
Conmed Q3 2026 Earnings Call Transcript
Conmed (NYSE:CNMD) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
-
4 days ago benzinga.com
Conmed Raises FY2026 Adj EPS Guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 Est; Narrows FY2026 Sales Guidance from $1.358B-$1.373B to $1.360B-$1.366B vs $1.366B Est
Conmed (NYSE:CNMD) raises FY2026 Adj EPS guidance from $4.48-$4.60 to $4.54-$4.61 vs $4.54 analyst estimate. Narrows FY2026 sales outlook from $1.358 billion-$1.373 billion to $1.360 billion-$1.366…
-
4 days ago benzinga.com
Conmed Q3 Adj. EPS $1.04 Beats $1.00 Estimate, Sales $335.557M Miss $336.226M Estimate
Conmed (NYSE:CNMD) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $1.00 by 4 percent. This is a 3.7 percent decrease over earnings of $1.08 per share from…
4 days ago businesswire.com
CONMED Corporation Reports Third Quarter 2026 Financial Results; Updates Full Year 2026 Guidance
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today reported financial results for the third quarter ended September 30, 2026 and updated its financial guidance for the full year…
3 weeks ago gurufocus.com
Is Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says Undervalued
On October 06, 2026, Conmed Corp (CNMD) shares fell 6.0% to a current price of $44.48, marking a significant decline in the context of a 52-week range of $31.44
1 month ago businesswire.com
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026.…
1 month ago zacks.com
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CONMED's BioBrace and AirSeal platforms, robotic growth and easing supply bottlenecks support its long-term outlook despite tariff headwinds.
2 months ago defenseworld.net
Canada Pension Plan Investment Board Buys Shares of 13,800 CONMED Corporation $CNMD
Canada Pension Plan Investment Board purchased a new position in CONMED Corporation (NYSE: CNMD) during the second quarter, according to the company in its most recent 13F filing with the Securities…
2 months ago zacks.com
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
2 months ago businesswire.com
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the…
2 months ago seekingalpha.com
CONMED Corporation: Organic Growth Is Masked By Divestitures
Conmed's headline growth appeared flat at $343 million in the last quarter, but organic growth actually increased by 6%, with the leading segment being the orthopedic surgery business. Growth was…
2 months ago zacks.com
CNMD Jumps 16% in a Month as Investors Assess Whether It Can Last
CNMD's 16% monthly rally is backed by stronger growth, margin gains and raised earnings guidance, but cash-flow and execution risks remain.
2 months ago zacks.com
Can CONMED's Raised 2026 EPS Outlook Reinforce Its Growth Momentum?
CONMED raised its 2026 adjusted EPS outlook after a strong second quarter, but slower organic growth and higher financing costs keep the setup mixed.
2 months ago zacks.com
Is CNMD a Buy Now as Low Valuation Meets Persistent Execution Risk?
CNMD's low valuation and improved earnings outlook strengthen its appeal, but cash-flow pressure and execution risks keep the buy case measured.
2 months ago zacks.com
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CONMED's growth outlook is supported by Buffalo Filter, BioBrace and organic momentum, though slower AirSeal growth and tariffs remain key risks.
2 months ago defenseworld.net
California State Teachers Retirement System Raises Stock Holdings in CONMED Corporation $CNMD
California State Teachers Retirement System lifted its stake in shares of CONMED Corporation (NYSE: CNMD) by 38.1% during the first quarter, according to the company in its most recent disclosure…
3 months ago defenseworld.net
Arrowstreet Capital Limited Partnership Purchases 287,150 Shares of CONMED Corporation $CNMD
Arrowstreet Capital Limited Partnership lifted its position in shares of CONMED Corporation (NYSE: CNMD) by 217.6% during the first quarter, according to the company in its most recent filing with…
-
3 months ago benzinga.com
Piper Sandler Reiterates Neutral on Conmed, Raises Price Target to $45
Piper Sandler analyst Matt O'Brien reiterates Conmed (NYSE:CNMD) with a Neutral and raises the price target from $39 to $45.
3 months ago zacks.com
CONMED Q2 Earnings and Revenues Beat Estimates, Gross Margin Expands
CNMD's Q2 earnings and revenues beat estimates, while margin growth and solid international sales support a higher 2026 EPS outlook.
-
3 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $46
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and raises the price target from $39 to $46.
3 months ago seekingalpha.com
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
CONMED Corporation (CNMD) Q2 2026 Earnings Call Transcript
-
3 months ago benzinga.com
Conmed Sees FY2026 Adj EPS $4.48-$4.60 vs $4.34 Est; Narrows FY2026 Sales Guidance from $1.350B-$1.375B to $1.358B-$1.373B vs $1.362B Est
Conmed (NYSE:CNMD) is looking for FY2026 Adj EPS of $4.48-$4.60 vs $4.34 analyst estimate. Narrows FY2026 sales outlook from $1.350 billion-$1.375 billion to $1.358 billion-$1.373 billion vs $1.362…
-
3 months ago benzinga.com
CONMED Says AirSeal Robotic Solution Is Now Indicated For Use With Intuitive’s 8 mm Hex Cannulas Used As Part Of Intuitive Da Vinci 5 Platform
CONMED Corporation (NYSE:CNMD) today announced that its AirSeal® Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the Intuitive da Vinci 5 platform…
3 months ago benzinga.com
TriCo Bancshares, Verra Mobility, Park Aerospace And Other Big Stocks Moving Higher On Monday
US stocks mixed, Dow Jones up 100 pts. TriCo Bancshares up 10% after First Hawaiian buyout. Other gainers: BRAI, VRRM, AIIO, CNMD, HELE, KRO, SM, GFR, GEVO, PARR, OIO, PKE.
3 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Q32 Bio (NASDAQ:QTTB) stock moved upwards by 44.4% to $16.19 during Friday's after-market session. The company's market cap stands at $213.4 million. China Pharma Holding (AMEX:CPHI) shares…
-
3 months ago benzinga.com
BMO Capital Initiates Coverage On Conmed with Market Perform Rating, Announces Price Target of $36
BMO Capital initiates coverage on Conmed (NYSE:CNMD) with a Market Perform rating and announces Price Target of $36.
-
4 months ago benzinga.com
B of A Securities Downgrades Conmed to Underperform, Maintains Price Target to $40
B of A Securities analyst Travis Steed downgrades Conmed (NYSE:CNMD) from Neutral to Underperform and maintains the price target from $40 to $40.
-
4 months ago benzinga.com
CONMED Appoints John E. Gallagher CFO, Effective July 15, Succeeding Todd Garner
CONMED Corporation (NYSE:CNMD) today announced the appointment of John E. Gallagher as Chief Financial Officer ("CFO"), effective July 15, 2026. Mr. Gallagher succeeds Todd Garner, who remains with…
-
5 months ago benzinga.com
B of A Securities Maintains Neutral on Conmed, Lowers Price Target to $40
B of A Securities analyst Travis Steed maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $52 to $40.
-
6 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $39
Wells Fargo analyst Larry Biegelsen maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $42 to $39.
-
6 months ago benzinga.com
JP Morgan Maintains Neutral on Conmed, Lowers Price Target to $40
JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $43 to $40.
-
6 months ago benzinga.com
Conmed Raises FY2026 Sales Guidance from $1.345B-$1.375B to $1.350B-$1.375B vs $1.359B Est
Conmed (NYSE:CNMD) raises FY2026 sales outlook from $1.345 billion-$1.375 billion to $1.350 billion-$1.375 billion vs $1.359 billion estimate.
-
6 months ago benzinga.com
Conmed Q1 Adj. EPS $0.89 Beats $0.82 Estimate, Sales $317.046M Beat $310.507M Estimate
Conmed (NYSE:CNMD) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $0.82 by 8.54 percent. This is a 6.32 percent decrease over earnings of $0.95 per share…
6 months ago benzinga.com
Earnings Scheduled For April 29, 2026
Earnings Scheduled For April 29, 2026
-
7 months ago benzinga.com
Clearmind Medicine Submits Patent Application With Intellectual Property Department In Hong Kong
Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second…
-
9 months ago benzinga.com
Earnings Scheduled For January 28, 2026
Earnings Scheduled For January 28, 2026
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
1 year ago benzinga.com
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook
Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For February 5, 2025
Earnings Scheduled For February 5, 2025
-
1 year ago benzinga.com
Top 3 Health Care Stocks That May Dip This Month
Top 3 Health Care Stocks That May Dip This Month
-
2 years ago benzinga.com
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.